Sanofi/Regeneron’s Dupixent could be first biologic approved for nasal polyps
Calliditas pushing on with kidney disease drug after IPO success
Roche and SQZ expand cell therapy deal to more than $1.3bn
Billions up for grabs as EU patent on AbbVie’s Humira expires
Sensyne’s gestational diabetes AI app launches on the NHS

COPD Foundation

Available on-demand: COPD, connecting real world needs to patient centric solutions

COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and

Available on-demand: COPD, connecting real world needs to patient centric solutions

https://pharmaphorum.com/debates-insight-patients/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

COPD Foundation

Available on-demand: COPD, connecting real world needs to patient centric solutions